Aardvark Therapeutics, Inc. (NASDAQ: AARD) reported Q3 EPS of ($0.75), $0.02 better than the analyst estimate of ($0.77).

For earnings history and earnings-related data on Aardvark Therapeutics, Inc. (AARD) click here.